BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24483602)

  • 1. Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
    Muthukumaran K; Leahy S; Harrison K; Sikorska M; Sandhu JK; Cohen J; Keshan C; Lopatin D; Miller H; Borowy-Borowski H; Lanthier P; Weinstock S; Pandey S
    BMC Neurosci; 2014 Jan; 15():21. PubMed ID: 24483602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.
    Sikorska M; Lanthier P; Miller H; Beyers M; Sodja C; Zurakowski B; Gangaraju S; Pandey S; Sandhu JK
    Neurobiol Aging; 2014 Oct; 35(10):2329-46. PubMed ID: 24775711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic susceptibility model of Parkinson's disease resulting from exposure of DJ-1 deficient mice to MPTP: evaluation of neuroprotection by Ubisol-Q10.
    Muthukumaran K; Smith J; Jasra H; Sikorska M; Sandhu JK; Cohen J; Lopatin D; Pandey S
    J Parkinsons Dis; 2014; 4(3):523-530. PubMed ID: 25061060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.
    Somayajulu-Niţu M; Sandhu JK; Cohen J; Sikorska M; Sridhar TS; Matei A; Borowy-Borowski H; Pandey S
    BMC Neurosci; 2009 Jul; 10():88. PubMed ID: 19635141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Ubisol-Q
    Vegh C; Wear D; Okaj I; Huggard R; Culmone L; Eren S; Cohen J; Rishi AK; Pandey S
    Antioxidants (Basel); 2021 Apr; 10(4):. PubMed ID: 33917328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubisol-Q10 Prevents Glutamate-Induced Cell Death by Blocking Mitochondrial Fragmentation and Permeability Transition Pore Opening.
    Kumari S; Mehta SL; Milledge GZ; Huang X; Li H; Li PA
    Int J Biol Sci; 2016; 12(6):688-700. PubMed ID: 27194946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resumption of Autophagy by Ubisol-Q
    Vegh C; Pupulin S; Wear D; Culmone L; Huggard R; Ma D; Pandey S
    Oxid Med Cell Longev; 2019; 2019():7404815. PubMed ID: 31934268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals.
    Attia HN; Maklad YA
    Behav Pharmacol; 2018 Feb; 29(1):79-86. PubMed ID: 28902670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S
    J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubisol-Q
    Wear D; Vegh C; Sandhu JK; Sikorska M; Cohen J; Pandey S
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34064983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction to: Orally delivered water soluble coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson's disease.
    Muthukumaran K; Leahy S; Harrison K; Sikorska M; Sandhu JK; Cohen J; Keshan C; Lopatin D; Miller H; Borowy-Borowski H; Lanthier P; Weinstock S; Pandey S
    BMC Neurosci; 2021 Dec; 22(1):79. PubMed ID: 34930123
    [No Abstract]   [Full Text] [Related]  

  • 12. Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease.
    Ahmad MH; Fatima M; Ali M; Rizvi MA; Mondal AC
    Neuropharmacology; 2021 Dec; 201():108831. PubMed ID: 34655599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10.
    McCarthy S; Somayajulu M; Sikorska M; Borowy-Borowski H; Pandey S
    Toxicol Appl Pharmacol; 2004 Nov; 201(1):21-31. PubMed ID: 15519605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson's disease rat model.
    Park HW; Park CG; Park M; Lee SH; Park HR; Lim J; Paek SH; Choy YB
    Sci Rep; 2020 Jun; 10(1):9572. PubMed ID: 32533070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of coenzyme Q10 in Parkinson's model via a novel Q10/miR-149-5p/MMPs pathway.
    Ghasemloo E; Mostafavi H; Hosseini M; Forouzandeh M; Eskandari M; Mousavi SS
    Metab Brain Dis; 2021 Oct; 36(7):2089-2100. PubMed ID: 34357552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
    McCormack AL; Thiruchelvam M; Manning-Bog AB; Thiffault C; Langston JW; Cory-Slechta DA; Di Monte DA
    Neurobiol Dis; 2002 Jul; 10(2):119-27. PubMed ID: 12127150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.
    Cleren C; Yang L; Lorenzo B; Calingasan NY; Schomer A; Sireci A; Wille EJ; Beal MF
    J Neurochem; 2008 Mar; 104(6):1613-21. PubMed ID: 17973981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration.
    Peng J; Peng L; Stevenson FF; Doctrow SR; Andersen JK
    J Neurosci; 2007 Jun; 27(26):6914-22. PubMed ID: 17596439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat.
    Hutson CB; Lazo CR; Mortazavi F; Giza CC; Hovda D; Chesselet MF
    J Neurotrauma; 2011 Sep; 28(9):1783-801. PubMed ID: 21644813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease.
    Mangano EN; Peters S; Litteljohn D; So R; Bethune C; Bobyn J; Clarke M; Hayley S
    Neurobiol Dis; 2011 Jul; 43(1):99-112. PubMed ID: 21377529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.